Full Text

Turn on search term navigation

Copyright © 2019 Seong-Hyop Kim et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0/

Details

Title
Corrigendum to “Total Intravenous Anaesthesia with High-Dose Remifentanil Does Not Aggravate Postoperative Nausea and Vomiting and Pain, Compared with Low-Dose Remifentanil: A Double-Blind and Randomized Trial”
Author
Kim, Seong-Hyop 1   VIAFID ORCID Logo  ; Chung-Sik Oh 2 ; Yoon, Tae-Gyoon 2 ; Min Jeng Cho 3 ; Jung-Hyun, Yang 3 ; Yi, Hye Ran 4 

 Department of Anaesthesiology and Pain Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Republic of Korea; Institute of Biomedical Science and Technology, Konkuk University School of Medicine, Seoul, Republic of Korea 
 Department of Anaesthesiology and Pain Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Republic of Korea 
 Department of Surgery, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Republic of Korea 
 Post-Anaesthetic Care Unit, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Republic of Korea 
Publication year
2019
Publication date
2019
Publisher
John Wiley & Sons, Inc.
ISSN
23566140
e-ISSN
1537744X
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2166677174
Copyright
Copyright © 2019 Seong-Hyop Kim et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0/